RPRX Royalty Pharma plc Chart, History Price & Graph

Key Takeaways

• RPRX maintains a bullish long-term trend, trading near its 52-week high of $50.47, with steady performance over the past six months showing a 34% gain.
• Key support levels at $45.35 and $42.75–$43.27; immediate resistance between $49.58–$50.10 and $50.47 high.
• RSI(14) at neutral levels around 45–58, indicating balanced momentum without overbought conditions.
• MACD shows slight negative divergence at -0.06 to -0.07, suggesting short-term caution amid the uptrend.
• Price above key longer-term moving averages (100-day and 200-day), supporting bullish bias despite mixed shorter-term signals.

Trend Analysis

Royalty Pharma plc (RPRX) has exhibited a robust uptrend over the past year, rising approximately 51% and advancing 28% year-to-date. The stock recently reached a 52-week high near $50.47 before consolidating around $49.47. Over the last 30 days, RPRX gained about 3%, reflecting controlled price action within a low-volatility environment (ATR at 1.86%). Chart patterns such as bull flags, ascending triangles, and double bottoms on daily and weekly timeframes underscore potential continuation of the bullish structure.

Support and Resistance Levels

Traders are monitoring pivotal support zones at $45.35, followed by $42.75–$43.27, $39.91, and $38.39, which align with prior consolidation areas and longer-term trendline bases. Classic pivot points place immediate support at $49.36 (S1), $49.16 (S2), and $49.06 (S3). On the upside, resistance clusters at $49.58–$50.10, with the 52-week high at $50.47 acting as a major barrier. Pivot resistances include $49.66 (R1), $49.76 (R2), and $49.95 (R3).

Momentum Indicators

The Relative Strength Index (RSI) at 45.63–58.49 registers neutral territory, neither overbought nor oversold, allowing room for further upside without immediate reversal risks. MACD (12,26,9) levels at -0.06 to -0.07 signal mild bearish divergence in the short term, with the histogram potentially flattening. Stochastic (9,6) at 22.21 indicates oversold conditions on shorter frames, while ADX at 22.10 suggests emerging trend strength.

Moving Averages

RPRX trades above its 100-day simple moving average (around $49.35) and 200-day ($48.36), reinforcing the primary uptrend. However, it sits below shorter-term averages like the 20-day ($49.75) and 50-day ($49.69), contributing to mixed signals. The 20-day moving average stands at $48.92, with 50-day at $47.33, indicating recent consolidation above rising longer-term supports.

Volume and Market Activity

Trading volume has remained steady without significant spikes, consistent with low volatility. Price action over the last quarter shows RPRX respecting dynamic supports from moving averages, with no major breakdowns observed. This measured behavior supports accumulation in supply zones near current levels.

Tickeron’s AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets, including technical indicators, price patterns, and historical trends for stocks like RPRX. These signals identify potential buy or sell opportunities by recognizing recurring market behaviors, trend shifts, and momentum changes. Traders rely on them to pinpoint entry/exit points, validate chart setups, and enhance decision-making amid volatile conditions. Generated daily, they provide objective insights complementing manual analysis. Explore AI Daily Buy/Sell Signals for RPRX to integrate AI-driven perspectives into your strategy.

Technical Outlook and Key Levels to Watch

Market participants eye a potential test of the $50.47 high if resistance at $49.58–$50.10 clears, with bullish patterns like flags and triangles offering continuation cues. A dip toward $45.35 support would test trend integrity, while monitoring RSI for divergence and MACD for crossovers remains crucial. Longer-term moving averages provide foundational support in this consolidation phase near recent peaks.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.